From May 20 to May 24, 2025, the global gene and cell therapy community will converge in New Orleans, USA, for the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT). As the premier international event in this rapidly evolving field, ASGCT 2025 will bring together over 3,000 leading scientists, clinicians, researchers, and industry pioneers from academia, industry, and regulatory bodies. This year's meeting promises to be a hub of innovation, showcasing groundbreaking research, cutting-edge technologies, and the future directions of gene and cell therapy. Since its inception in 1996, the ASGCT Annual Meeting has been the cornerstone of scientific advancement in this domain, fostering collaboration and knowledge-sharing among global experts. 

JOINN, a leader in non-clinical Contract Research Organization (CRO) services in China, is proud to participate in this landmark event. At ASGCT 2025, JOINN will showcase its extensive expertise in gene and cell therapy through an on-site booth (Booth No. #1356), engaging in meaningful discussions with attendees. With a track record of supporting numerous gene and cell therapy products from early research stages to Investigational New Drug (IND) filings, JOINN has established itself as a trusted partner in the industry. Our team specializes in providing high-quality non-clinical safety evaluations, ensuring that innovative therapies meet rigorous global standards. From gene editing to viral vector design and cell therapy assessments, JOINN leverages deep technical expertise and a highly skilled team to accelerate the development of life-changing treatments. At this year’s conference, JOINN looks forward to collaborating with global peers, advancing the frontiers of gene and cell therapy, and contributing to the health and well-being of patients worldwide.

Welcome to click on "Schedule a Meeting" below to set the meeting time. We look forward to meeting you!